Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development

D.T. Klink, R.M. van Elburg, M.W.J. Schreurs, G.T.J. van Well

Research output: Contribution to journalArticleAcademicpeer-review

34 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)271363
JournalClinical & Developmental Immunology
Volume2008
DOIs
Publication statusPublished - 2008

Cite this

@article{fc2334218d964f2baef33dfd8a1057b1,
title = "Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development",
author = "D.T. Klink and {van Elburg}, R.M. and M.W.J. Schreurs and {van Well}, G.T.J.",
year = "2008",
doi = "10.1155/2008/271363",
language = "Undefined/Unknown",
volume = "2008",
pages = "271363",
journal = "Clinical & Developmental Immunology",
issn = "1740-2522",
publisher = "Hindawi Publishing Corporation",

}

Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. / Klink, D.T.; van Elburg, R.M.; Schreurs, M.W.J.; van Well, G.T.J.

In: Clinical & Developmental Immunology, Vol. 2008, 2008, p. 271363.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development

AU - Klink, D.T.

AU - van Elburg, R.M.

AU - Schreurs, M.W.J.

AU - van Well, G.T.J.

PY - 2008

Y1 - 2008

U2 - 10.1155/2008/271363

DO - 10.1155/2008/271363

M3 - Article

VL - 2008

SP - 271363

JO - Clinical & Developmental Immunology

JF - Clinical & Developmental Immunology

SN - 1740-2522

ER -